Publication

Byline

Clinical Trial: Effect of Physical Activity on the Course of Parkinson's Disease in Patients With Bilateral DBS-STN Stimulation - a Randomized Controlled Trial.

U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07838636) titled 'Effect of Physical Activity on the Course of Parkinson's Disease in Patients With Bilatera... और पढ़ें


Singapore Clinical Trial: Evaluating the Year-Round Immunogenicity of Standard-Dose Versus High-Dose Seasonal Influenza Vaccines in Adults Aged 60 Years or Older in Singapore (SingVax-01)

Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'Evaluating the Year-Round Immunogenicity of Standard-Dose Versus High-Dose Seasonal Influenza Vac... और पढ़ें


Clinical Trial: EFFICACY AND TOLERANCE OF AN EMOLLIENT CREAM IN SKIN OF COLOR

U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07839897) titled 'EFFICACY AND TOLERANCE OF AN EMOLLIENT CREAM IN SKIN OF COLOR' on Sept. 18. Brief Summary... और पढ़ें


Singapore Clinical Trial: Beamion LUNG-1: An open label, Phase I dose escalation trial, with dose confirmation and expansion, of zongertinib (BI 1810631) as monotherapy in patients with advanced or metastatic solid tumors with HER2 aberrations

Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-1: An open label, Phase I dose escalation trial, with dose confirmation and expansio... और पढ़ें


Singapore Clinical Trial: A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutamide Compared with ARPI or Docetaxel in Patients with Metastatic Castration Resistant Prostate Cancer Previously Treated with Abiraterone Acetate (Himalayas-1)

Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutam... और पढ़ें


Singapore Clinical Trial: Tucatinib continuation protocol: an open label study for participants from tucatinib clinical studies

Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'Tucatinib continuation protocol: an open label study for participants from tucatinib clinical stu... और पढ़ें


Clinical Trial: Fractional CO2 Laser vs Dermabrasion With 5-Fluorouracil for Acquired Leukoderma

U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07837908) titled 'Fractional CO2 Laser vs Dermabrasion With 5-Fluorouracil for Acquired Leukoderma' on Sept.... और पढ़ें


Singapore Clinical Trial: A PHASE III, MULTICENTER, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF SUBCUTANEOUS INDUCTION THERAPY WITH AFIMKIBART IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A PHASE III, MULTICENTER, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY... और पढ़ें


Singapore Clinical Trial: An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-08634404 in Combination With Chemotherapy Versus Pembrolizumab in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent Mismatch Repair (MMR) Proficient Endometrial Cancer

Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-086... और पढ़ें


Singapore Clinical Trial: A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib (RMC-9805) as First Line Treatment in Patients With Metastatic Non-squamous RAS G12D-Mutated Non-small Cell Lung Cancer (RASolve 308)

Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy W... और पढ़ें